As you know, Scistats has been promoting the idea that Corrigan is working overtime to get top-line Z160 LSR results out ASAP....perhaps by October 7th.
What goes against this theory to me is that most expect ZLCS to release PHN--NOT LSR-- results first, since the PHN trial is more likely to be positive. (It seems obvious that if one Z160 trial were positive and one were negative, they would need to announce the positive trial first. Otherwise, the stock would get pummelled with negative results first, and the subsequent positive trial results might fall on deaf ears).
So I expect PHN results first, and therefore doubt any results will announced by October 7th.
HOWEVER, should they surprise me and announce positive LSR results first, they sky's the limit....because the likelihood of subsequent positive PHN results is quite good!!!
Why not release interim results? My conjecture is that if the results are going well that Corrigan will release something before Oct 7th that prelim data or interim results are looking good. I have seen this done before. If silence before Oct 7, then I believe likely we have a failed trial or have to do data mining to redesign another trial.
I am long and want to see this stock run as much as anyone else, but I don't see how the CEO working overtime can speed up a clinical trial? Isn't the time frame based on a specific date range that the patients are using the drug. They can't change that date range can they? It is going to take retail speculation to get this to $1 and avoid a split before results come out. If it does split and resluts are good the higher stock price will not matter.